bioSyntagma is located in Phoenix, United States on 275 N. Gateway Drive Suite 124. bioSyntagma is rated 3 out of 5 in the category biotechnology in United States. bioSyntagma is a precision medicine company dedicated to transforming how cancer is treated by providing deep data on the uniqueness of each person’s cancer. The company’s Molecular Fingerprint™ (mPrint™) platform creates a comprehensive, multi-omic and spatial profile of tissue to get a complete and informed understanding of the patient’s cancer so they can be matched with relevant therapies and recommended course of actions that prevent acquired drug resistance. bioSyntagma’s mPrint™ platform serves the needs of clinicians, academic researchers, and drug developers to advance the implementation of precision medicine for cancer treatment.
Address
275 N. Gateway Drive Suite 124
Company size
1-10 employees
Headquarters
Phoenix, Arizona